project id: TCGA-OV; case submitter id: TCGA-61-2003; source center: 22; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 7.6; spectrophotometer method: UV Spec; age at index: 53; days to birth: -19605; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1955; age at diagnosis: 19605; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 122.0; figo stage: Stage IIIC; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 2008; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 1.4; longest dimension: 1.5; preservation method: Unknown; shortest dimension: 0.2; sample id: 74826da0-ddc4-49b0-bcb5-591691f4f8d6; sample submitter id: TCGA-61-2003-01A; portion id: 44425f5b-5bc1-49eb-82a9-62d70f2d62cb; portion submitter id: TCGA-61-2003-01A-01; percent necrosis: 3.0; percent normal cells: 7.0; percent stromal cells: 5.0; percent tumor cells: 85.0; percent tumor nuclei: 95.0;